S100A9 and melanoma: Recombinant S100A9, a calcium-binding protein A9, which is known as migration inhibitory factor has been shown to reduce the A-375 melanoma cell line proliferation and down-regulate OCLN gene expression in a time- and dose-dependent manner (41).